UNSPSC 51286901: Carbadox

This classification denotes an anti-infective agent with the molecular formula C11H10N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M2X04R2E2Y, chemically known as 3-(2-quinoxalinylmethylene)carbazic acid methyl ester n,n-dioxide but more generally known as carbadox, which bears US NIH Compound Identifier 5353472. European Medicines Agency schedules Carbadox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06088MIG. The term CARBADOX is an International Non-Proprietary Name.

CARBADOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: COC(=O)N=N/C=C/1\C=[N+](C2=CC=CC=C2N1O)[O-].

UNSPSC 51286901 Carbadox is a Commodity code that encompasses pharmaceutical and healthcare products, though recent state and local solicitations tagged under this code show procurement activity focused on emergency medical supplies, naloxone, pharmaceutical distribution, and over-the-counter products rather than carbadox specifically. State and local buyers under this code include county health agencies, municipal fire departments, state health and human services commissions, and multistate cooperative purchasing alliances. The work involves sourcing pharmaceuticals, emergency medical consumables, first aid supplies, and drug-related public health products for community health initiatives, emergency response operations, and state pharmacy benefit programs. Issuing bodies range from county-level health departments to state-level HHS agencies and regional cooperative purchasing vehicles that coordinate procurement across multiple jurisdictions.

The geographic spread of recent activity includes Florida, Texas, and Minnesota, with multistate implications through cooperative purchasing arrangements. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's invitation to bid 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies estimated at $700,000.00 and designated as a sheltered market for certified Small Local Business Enterprises; the Texas Health and Human Services Commission's Request for Information HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers to state and local facilities across multiple states.